Nanvuranlat

N/A

Report date: 2026/04/10 20:01:49
NME

Base Information

Drug NameNanvuranlat
Drug Alias NameJPH-203SBECDJPH-203KYT-0353
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionL-type amino acid transporter 1 inhibitors
TargetsL-type amino acid transporter 1
Therapy Area/IndicationsBiliary Tract Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesJ-Pharma
China Registration ClassN/A

Develop Information

Active CompaniesJ-Pharma
Inactive CompaniesN/A
Active IndicationsBiliary Tract Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A